Effects oficaffeine on the human circadian clock in vivo and in vitro

Science Translational Medicine

Volumn 7, Issue 305, 2015, Pages

  Burke, Tina M ^a   Markwald, Rachel R ^a,c   McHill, Andrew W ^a,d   Chinoy, Evan D ^a,d   Snider, Jesse A ^a   Bessman, Sara C ^a,c   Jung, Christopher M ^a,e   O'Neill, John S ^b   Wright, Kenneth P ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ALASKA ANCHORAGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; CAFFEINE; CYCLIC AMP; LUCIFERASE; MELATONIN; PHOSPHODIESTERASE; RYANODINE RECEPTOR; SMALL INTERFERING RNA;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYMIC BIOSENSOR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR MECHANICS; NORMAL HUMAN; OSCILLATION; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; SLEEP TIME; YOUNG ADULT; ANALYSIS OF VARIANCE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; GENETIC PROCEDURES; LUMINESCENCE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; TUMOR CELL LINE;

ADULT; ANALYSIS OF VARIANCE; BIOSENSING TECHNIQUES; CAFFEINE; CELL LINE, TUMOR; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LUMINESCENCE; MALE; MELATONIN; RNA, SMALL INTERFERING; YOUNG ADULT;

EID: 84941795831     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aac5125     Document Type: Article

References (48)

1. C. A. Czeisler, J. S. Allan, S. H. Strogatz, J. M. Ronda, R. Sánchez, C. D. Ríos, W. O. Freitag, G. S. Richardson, R. E. Kronauer, Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle. Science 233, 667-671 (1986).
2. K. P. Wright Jr., C. A. Czeisler, Absence oficircadian phase resetting in response to bright light behind the knees. Science 297, 571 (2002).
3. S. B. Khalsa, M. E. Jewett, C. Cajochen, C. A. Czeisler, A phase response curve to single bright light pulses in human subjects. J. Physiol. 549, 945-952 (2003).
4. 1, receptors mediate the arousal effect oficaffeine. Nat. Neurosci. 8, 858-859 (2005).
5. A. Nehlig, J. Daval, G. Debry, Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Brain Res. Rev. 17, 139-170 (1992).
6. J. C. Shryock, M. J. Ozeck, L. Belardinelli, Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol. Pharmacol. 53, 886-893 (1998).
7. 2A receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 19, 1283-1293 (2011).
8. J.-F. Chen, H. K. Eltzschig, B. B. Fredholm, Adenosine receptors as drug targets-What are the challenges? Nat. Rev. Drug Discov. 12, 265-286 (2013).
9. J. F. Feldman, Circadian periodicity in neurospora: Alteration by inhibitors oficyclic AMP phosphodiesterase. Science 190, 789-790 (1975).
10. J. E. Goodenough, V. G. Bruce, The effects oficaffeine and theophylline on the phototactic rhythm of Chlamydomonas reinhardii. Biol. Bull. 159, 649-655 (1980).
11. M. N. Wu, K. Ho, A. Crocker, Z. Yue, K. Koh, A. Sehgal, The effects oficaffeine on sleep in Drosophila require PKA activity, but not the adenosine receptor. J. Neurosci. 29, 11029-11037 (2009).
12. M. R. Ralph, S. B. S. Khalsa, G. D. Block, Cyclic nucleotides and circadian rhythm generation in Bulla gouldiana. Comp. Biochem. Physiol. A Physiol. 101, 813-817 (1992).
13. K. P. Wright Jr., P. Badia, B. L. Myers, S. C. Plenzler, M. Hakel, Caffeine and light effectsonnighttime melatonin and temperature levels in sleep-deprived humans. Brain Res. 747, 78-84 (1997).
14. K. P. Wright Jr., B. L. Myers, S. C. Plenzler, C. L. Drake, P. Badia, Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives. Brain Res. 873, 310-317 (2000).
15. L. P. Shearman, D. R. Weaver, Distinct pharmacological mechanisms leading to c-fos gene expression in the fetal suprachiasmatic nucleus. J. Biol. Rhythms 16, 531-540 (2001).
16. J. M. Ding, G. F. Buchanan, S. A. Tischkau, D. Chen, L. Kuriashkina, L. E. Faiman, J. M. Alster, P. S. McPherson, K. P. Campbell, M. U. Gillette, A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock. Nature 394, 381-384 (1998).
17. M. Díaz-Muñoz, M. A. Dent, D. Granados-Fuentes, A. C. Hall, A. Hernández-Cruz, M. E. Harrington, R. Aguilar-Roblero, Circadian modulation of the ryanodine receptor type 2 in the SCN of rodents. Neuroreport 10, 481-486 (1999).
18. H. Oike, M. Kobori, T. Suzuki, N. Ishida, Caffeine lengthens circadian rhythms in mice. Biochem. Biophys. Res. Commun. 410, 654-658 (2011).
19. K. P. Wright Jr., A. W. McHill, B. R. Birks, B. R. Griffin, T. Rusterholz, E. D. Chinoy, Entrainment of the human circadian clock to the natural light-dark cycle. Curr. Biol. 23, 1554-1558 (2013).
20. T. M. Burke, R. R. Markwald, E. D. Chinoy, J. A. Snider, S. C. Bessman, C. M. Jung, K. P. Wright Jr., Combination of light and melatonin time cues for phase advancing the human circadian clock. Sleep 36, 1617-1624 (2013).
21. J. M. Zeitzer, D.-J. Dijk, R. E. Kronauer, E. N. Brown, C. A. Czeisler, Sensitivity of the human circadian pacemaker to nocturnal light: Melatonin phase resetting and suppression. J. Physiol. 526, 695-702 (2000).
22. K. P. Wright Jr., R. J. Hughes, R. E. Kronauer, D.-J. Dijk, C. A. Czeisler, Intrinsic near-24-h pacemaker period determines limits oficircadian entrainment to a weak synchronizer in humans. Proc. Natl. Acad. Sci. U. S. A. 98, 14027-14032 (2001).
23. J. F. Duffy, S. W. Cain, A.-M. Chang, A. J. Phillips, M. Y. Münch, C. Gronfier, J. K. Wyatt, D.-J. Dijk, K. P. Wright Jr., C. A. Czeisler, Sex difference in the near-24-hour intrinsic period of the human circadian timing system. Proc. Natl. Acad. Sci. U. S. A. 108, 15602-15608 (2011).
24. M. R. Smith, H. J. Burgess, L. F. Fogg, C. I. Eastman, Racial differences in the human endogenous circadian period. PLOS One 4, e6014 (2009).
25. 2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin. Pharmacol. Ther. 81, 692-698 (2007).
26. 2A receptor is associated with habitual caffeine consumption. Am. J. Clin. Nutr. 86, 240-244 (2007).
27. E. M. Byrne, J. Johnson, A. F. McRae, D. R. Nyholt, S. E. Medland, P. R. Gehrman, A. C. Heath, P. A. Madden, G. W. Montgomery, G. Chenevix-Trench, N. G. Martin, A genome-wide association study oficaffeine-related sleep disturbance: Confirmation of a role for a common variant in the adenosine receptor. Sleep 35, 967-975 (2012).
28. H. C. Van Diepen, E. A. Lucassen, R. Yasenkov, I. Groenen, A. P. Ijzerman, J. H. Meijer, T. Deboer, Caffeine increases light responsiveness of the mouse circadian pacemaker. Eur. J. Neurosci. 40, 3504-3511 (2014).
29. D. G. Monroe, F. J. Secreto, M. Subramaniam, B. J. Getz, S. Khosla, T. C. Spelsberg, Estrogen receptor a and b heterodimers exert unique effects on estrogen- and tamoxifendependent gene expression in human U2OS osteosarcoma cells. Mol. Endocrinol. 19, 1555-1568 (2005).
30. G. Chen, A. N. Van Den Pol, Adenosine modulation oficalcium currents and presynaptic inhibition of GABA release in suprachiasmatic and arcuate nucleus neurons. J. Neurophysiol. 77, 3035-3047 (1997).
31. L. A. Conlay, J. A. Conant, F. De Bros, R. Wurtman, Caffeine alters plasma adenosine levels. Nature 389, 136 (1997).
32. J. S. O'Neill, E. S. Maywood, J. E. Chesham, J. S. Takahashi, M. H. Hastings, cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 320, 949-953 (2008).
33. Y. Isojima, M. Nakajima, H. Ukai, H. Fujishima, R. G. Yamada, K.-H. Masumoto, R. Kiuchi, M. Ishida, M. Ukai-Tadenuma, Y. Minami, R. Kito, K. Nakao, W. Kishimoto, S.-H. Yoo, K. Shimomura, T. Takao, A. Takano, T. Kojima, K. Nagai, Y. Sakaki, J. S. Takahashi, H. R. Ueda, CKIe/5-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock. Proc. Natl. Acad. Sci. USA. 106, 15744-15749 (2009).
34. P. H. Wu, J. W. Phillis, M. J. Nye, Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: Evaluation of structureactivity relationships. Life Sci. 31, 2857-2867 (1982).
35. M. Doi, A. Ishida, A. Miyake, M. Sato, R. Komatsu, F. Yamazaki, I. Kimura, S. Tsuchiya, H. Kori, K. Seo, Y. Yamaguchi, M. Matsuo, J.-M. Fustin, R. Tanaka, Y. Santo, H. Yamada, Y. Takahashi, M. Araki, K. Nakao, S. Aizawa, M. Kobayashi, K. Obrietan, G. Tsujimoto, H. Okamura, Circadian regulation of intracellular G-protein signalling mediates intercellular synchrony and rhythmicity in the suprachiasmatic nucleus. Nat. Commun. 2, 327 (2011).
36. J. S. O'Neill, G. Van Ooijen, L. E. Dixon, C. Troein, F. Corellou, F.-Y. Bouget, A. B. Reddy, A. J. Millar, Circadian rhythms persist without transcription in a eukaryote. Nature 469, 554-558 (2011).
37. Z. Chen, S.-H. Yoo, J. S. Takahashi, Small molecule modifiers oficircadian clocks. Cell. Mol. Life Sci. 70, 2985-2998 (2013).
38. E. E. Zhang, Y. Liu, R. Dentin, P. Y. Pongsawakul, A. C. Liu, T. Hirota, D. A. Nusinow, X. Sun, S. Landais, Y. Kodama, D. A. Brenner, M. Montminy, S. A. Kay, Cryptochrome mediates circadian regulation oficAMP signaling and hepatic gluconeogenesis. Nat. Med. 16 1152-1156 (2010).
39. S. Narishige, M. Kuwahara, A. Shinozaki, S. Okada, Y. Ikeda, M. Kamagata, Y. Tahara, S. Shibata, Effects oficaffeine on circadian phase, amplitude and period evaluated in cells in vitro and peripheral organs in vivo in PER2::LUCIFERASE mice. Br. J. Pharmacol. 171, 5858-5869 (2014).
40. R. Zhang, N. F. Lahens, H. I. Ballance, M. E. Hughes, J. B. Hogenesch, A circadian gene expression atlas in mammals: Implications for biology and medicine. Proc. Natl. Acad. Sci. U. SA. 111, 16219-16224 (2014).
41. A. Watanabe, T. Moriya, Y. Nisikawa, T. Araki, T. Hamada, S. Shibata, S. Watanabe, Adenosine A1-receptor agonist attenuates the light-induced phase shifts and fos expression in vivo and optic nerve stimulation-evoked field potentials in the suprachiasmatic nucleus in vitro. Brain Res. 740, 329-336 (1996).
42. A. Kvanta, S. Seregard, S. Sejersen, B. Kull, B. B. Fredholm, Localization of adenosine receptor messenger RNAs in the rat eye. Exp. Eye Res. 65, 595-602 (1997).
43. K. Ishihara, A. Miyasita, M. Inugami, K. Fukuda, K. Yamazaki, Y. Miyata, Differences in the time or frequency of meals, alcohol and caffeine ingestion, and smoking found between 'morning' and 'evening' types. Psychol. Rep. 57, 391-396 (1985).
44. K. O. McGraw, S. P. Wong, Forming inferences about some intraclass correlation coefficients. Psychol. Methods 1, 30-46 (1996).
45. J. R. Landis, G. G. Koch, The measurement of observer agreement for categorical data. Biometrics 33, 159-174 (1977).
46. U. K. Valekunja, R. S. Edgar, M. Oklejewicz, G. T. Van Der Horst, J. S. O'Neill, F. Tamanini, D. J. Turner, A. B. Reddy, Histone methyltransferase MLL3 contributes to genome-scale circadian transcription. Proc. Natl. Acad. Sci. USA. 110, 1554-1559 (2013).
47. J. S. O'Neill, M. H. Hastings, Increased coherence oficircadian rhythms in mature fibroblast cultures. J. Biol. Rhythms 23, 483-488 (2008).
48. T. Hirota, W. G. Lewis, A. C Liu, J. W. Lee, P. G. Schultz, S. A. Kay, A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3|3. Proc. Natl. Acad. Sci. USA. 105, 20746-20751 (2008).